Home Compounds Cognitive & Mood DSIP
Cognitive & Mood Research Preliminary

DSIP

Delta Sleep-Inducing Peptide — neuropeptide studied for sleep architecture improvement, stress reduction, and HPA axis modulation.

sleepdelta waveHPA axiscortisolstressneuropeptide
Half-life
Very short; minutes
SKUs
2
Evidence
Preliminary

DSIP (Delta Sleep-Inducing Peptide) is a short peptide that was originally isolated from rabbit brain in the 1970s based on its ability to induce delta-wave sleep in animal research. It has since been studied for a broader range of effects including stress response modulation, pain, and neuroendocrine function. Most research remains preclinical, with limited human data.

Sleep Research
DSIP was named for its original observed effect of increasing delta sleep (deep slow-wave sleep) in animal experiments. Early studies in humans showed some effects on sleep architecture, though results have been inconsistent and subsequent research has not strongly confirmed reliable sleep-promoting effects.
Stress and Neuroendocrine Research
Research has examined DSIP's effects on stress hormones, finding some evidence that it can modulate the cortisol response and reduce signs of stress in animal models. Its relationship to the hypothalamic-pituitary-adrenal (HPA) axis has been a research focus.
Pain Research
Some studies have examined DSIP for analgesic effects, reporting pain-reducing responses in animal models. The mechanism proposed involves interaction with opioid and somatostatin pathways, though this is not well-established.
  • Original animal research demonstrated increased delta sleep following administration.
  • Human sleep studies have produced inconsistent results.
  • Some evidence of stress hormone modulation in animal research.
  • Analgesic effects observed in some animal studies.
  • Limited and inconsistent human data overall.

DSIP's research history is characterized by inconsistent results. The sleep-inducing effects that gave it its name have not been reliably reproduced across studies, and human clinical trials have generally been small and inconclusive. The compound degrades rapidly in circulation, making stable research challenging. It is not approved for any use, and the existing evidence does not support strong conclusions about its effects in people.

DSIP is a nine-amino-acid peptide that appears to interact with multiple receptor systems in the brain, including pathways involved in sleep regulation, stress response, and pain signaling. Unlike most pharmaceutical compounds that target a single well-defined receptor, DSIP seems to influence several systems simultaneously. Researchers think it may act on receptors involved in regulating the transition between sleep states, and that it may modulate the release of stress hormones from the adrenal glands. The peptide's widespread effects across multiple systems are part of why its pharmacology is difficult to pin down precisely.

DSIP has been used in small human studies without reports of significant adverse effects. However, the evidence base is too limited to draw firm safety conclusions. It is not FDA-approved. The fact that it was originally isolated from animal brain tissue means that research on synthetic versions must consider whether the synthetic form behaves identically to the natural peptide.

Preliminary

Most evidence comes from preclinical studies and case reports. Human data is limited and more research is needed.

Published Research Ranges
0.5–30 nmol/kg in human studies
Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.

Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.

Delta Sleep-Inducing Peptide: A Review of Biological Activity
Neuropeptides • 1984  • DOI: 10.1016/0143-4179(84)90010-0
View Source
DSIP in Stress and Sleep Disorders: Clinical Observations
Peptides • 1994  • DOI: 10.1016/0196-9781(94)90173-2
View Source
Somnogenic Peptides and Their Role in Sleep Regulation
International Review of Neurobiology • 1994  • DOI: 10.1016/S0074-7742(08)60247-5
View Source
Morphine-like insomnia from heroin in nondependent human addicts
 • 1981  • DOI: 10.1111/j.1365-2125.1981.tb01120.x
View Source
Circadian Variation in Human Milk Composition, a Systematic Review
 • 2020  • DOI: 10.3390/nu12082328
View Source
Circadian rhythms in the blood-brain barrier: impact on neurological disorders and stress responses
 • 2023  • DOI: 10.1186/s13041-023-00997-0
View Source
Long COVID: major findings, mechanisms and recommendations
 • 2023  • DOI: 10.1038/s41579-022-00846-2
View Source
The immunology and immunopathology of COVID-19
 • 2022  • DOI: 10.1126/science.abm8108
View Source
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
 • 2022  • DOI: 10.1038/s41392-022-01073-0
View Source
Alzheimer disease
 • 2021  • DOI: 10.1038/s41572-021-00269-y
View Source
Duchenne muscular dystrophy
 • 2021  • DOI: 10.1038/s41572-021-00248-3
View Source
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
 • 2021  • DOI: 10.3389/fmicb.2021.698169
View Source
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
 • 2021  • DOI: 10.1124/pharmrev.120.000131
View Source
Neurological associations of COVID-19
 • 2020  • DOI: 10.1016/s1474-4422(20)30221-0
View Source
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
 • 2020  • DOI: 10.1093/neuonc/noaa106
View Source
Locus coeruleus: a new look at the blue spot
 • 2020  • DOI: 10.1038/s41583-020-0360-9
View Source
Gastric cancer: a comprehensive review of current and future treatment strategies
 • 2020  • DOI: 10.1007/s10555-020-09925-3
View Source
Regulation of the Blood-Brain Barrier by Circadian Rhythms and Sleep
 • 2019  • DOI: 10.1016/j.tins.2019.05.001
View Source
The Sleep-Immune Crosstalk in Health and Disease
 • 2019  • DOI: 10.1152/physrev.00010.2018
View Source
European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders
 • 2019  • DOI: 10.1177/2050640619844125
View Source
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
 • 2018  • DOI: 10.1152/physrev.00038.2017
View Source
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association
 • 2017  • DOI: 10.1161/cir.0000000000000485
View Source
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
 • 2017  • DOI: 10.1212/wnl.0000000000004058
View Source
Neural Circuitry of Wakefulness and Sleep
 • 2017  • DOI: 10.1016/j.neuron.2017.01.014
View Source
Hippocampal GABAergic Inhibitory Interneurons
 • 2017  • DOI: 10.1152/physrev.00007.2017
View Source
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
 • 2017  • DOI: 10.1681/asn.2016060666
View Source
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
 • 2016  • DOI: 10.3389/fpsyt.2016.00072
View Source
Central Nervous System Oxygen Toxicity and Hyperbaric Oxygen Seizures
 • 2016  • DOI: 10.3357/amhp.4463.2016
View Source
Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders
 • 2016  • DOI: 10.1038/mp.2016.1
View Source
Peptides and the blood-brain barrier
 • 2015  • DOI: 10.1016/j.peptides.2015.03.010
View Source
Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine
 • 2006  • DOI: 10.1038/sj.npp.1300923
View Source
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
 • 2021  • DOI: 10.1002/14651858.cd013600.pub4
View Source
Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research
 • 2020  • DOI: 10.1016/j.smrv.2019.101250
View Source
Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review
 • 2015  • DOI: 10.2174/1570159x13666141210222725
View Source
The role of neuropeptides in suicidal behavior: a systematic review
 • 2013  • DOI: 10.1155/2013/687575
View Source
Breast cancer: pathogenesis and treatments
 • 2025  • DOI: 10.1038/s41392-024-02108-4
View Source
Research progress on the correlation between biological rhythms and the blood-brain barrier after ischemic stroke
 • 2025  • DOI: 10.3389/fneur.2025.1627172
View Source
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
 • 2024  • DOI: 10.1038/s41392-023-01688-x
View Source
Targeting immunogenic cell stress and death for cancer therapy
 • 2024  • DOI: 10.1038/s41573-024-00920-9
View Source
Circadian Rhythms of the Blood-Brain Barrier and Drug Delivery
 • 2024  • DOI: 10.1161/circresaha.123.323521
View Source
Emerging phagocytosis checkpoints in cancer immunotherapy
 • 2023  • DOI: 10.1038/s41392-023-01365-z
View Source
Neuro-orchestration of sleep and wakefulness
 • 2023  • DOI: 10.1038/s41593-022-01236-w
View Source
Promising applications of human-derived saliva biomarker testing in clinical diagnostics
 • 2023  • DOI: 10.1038/s41368-022-00209-w
View Source
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
 • 2022  • DOI: 10.3389/fnmol.2022.919773
View Source
Circadian rhythms and cancers: the intrinsic links and therapeutic potentials
 • 2022  • DOI: 10.1186/s13045-022-01238-y
View Source
The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression
 • 2022  • DOI: 10.3389/fpsyt.2022.871754
View Source
Evidence-Based Effects of High-Intensity Interval Training on Exercise Capacity and Health: A Review with Historical Perspective
 • 2021  • DOI: 10.3390/ijerph18137201
View Source
Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases
 • 2021  • DOI: 10.3389/fnins.2021.650971
View Source
A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
 • 2021  • DOI: 10.3390/cancers13081795
View Source
Disruptions of Circadian Rhythms and Thrombolytic Therapy During Ischemic Stroke Intervention
 • 2021  • DOI: 10.3389/fnins.2021.675732
View Source
Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions
 • 2021  • DOI: 10.3390/microorganisms9020353
View Source
Communicating clocks shape circadian homeostasis
 • 2021  • DOI: 10.1126/science.abd0951
View Source
Pathophysiological implications of hypoxia in human diseases
 • 2020  • DOI: 10.1186/s12929-020-00658-7
View Source
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
 • 2020  • DOI: 10.1038/s41386-019-0446-0
View Source
Hematopoiesis and Cardiovascular Disease
 • 2020  • DOI: 10.1161/circresaha.120.315895
View Source
The Locus Coeruleus- Norepinephrine System in Stress and Arousal: Unraveling Historical, Current, and Future Perspectives
 • 2020  • DOI: 10.3389/fpsyt.2020.601519
View Source
Starvation Responses Throughout the Caenorhabditiselegans Life Cycle
 • 2020  • DOI: 10.1534/genetics.120.303565
View Source
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
 • 2020  • DOI: 10.1038/s41386-019-0439-z
View Source
The Urothelium: Life in a Liquid Environment
 • 2020  • DOI: 10.1152/physrev.00041.2019
View Source
Targeting REV-ERBα for therapeutic purposes: promises and challenges
 • 2020  • DOI: 10.7150/thno.43834
View Source

60 sources · Platform research library · Not generated by AI

DS5DS10

Combination use is not endorsed - provided for research context only.

Want More Detailed Research?

Ask the AI anything about DSIP - mechanisms, trial summaries, pharmacokinetics, and comparisons.

Ask AI About DSIP
Research Education Only: This profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions.